Initial public offer consisting of fresh issue of 19,76,000 equity shares of face value of Rs. 10/- each fully paid for cash at a price of Rs. 72 per equity share (the issue price) (including a share premium of Rs. 62 per equity share) aggregating up to Rs. 14.23 crores (the issue). of which 1,04,000 equity shares of face value of Rs. 10/- each for cash at a price of Rs. 72/- per equity share, aggregating Rs. 0.75 crores will be reserved for subscription by the market maker to the issue (the market maker reservation portion). The issue less market maker reservation portion i.e. issue 18,72.000 equity shares of face value of Rs. 10/- each for cash at a price of Rs. 72/- per equity share, aggregating Rs. 13.48 crores is hereinafter referred to as the net issue. The issue and the net issue will constitute 29.98% and 28.40% respectively of the fully diluted post issue paid up equity share capital of the company.The face value of equity shares is Rs.10/- each.The issue price is Rs.72/- and is 7.2 times the face value of the equity shares.
Money Payable On
Further Multiples of: 1600
706 to 709 7th Floor Aravali Business Centre Borivali(W) Mumbai
Phone - 91-22-28928833
Fax - 91-22-28928833
Email - email@example.com
Website - www.vaishalipharma.com